Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Escalating Doses of Intravenous Zidebactam in Healthy Adult Human Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Zidebactam (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- Acronyms MAD
- Sponsors Wockhardt
- 03 Aug 2016 Status changed from not yet recruiting to completed.
- 15 Feb 2016 New trial record